Scott Snapper News Today

Drs Peter Higgins and Jean-Frederic Colombel discuss exciting new evidence in Crohns disease research that may help in identifying those at risk before disease starts and pave the way for a vaccine.

News Category Global Banking & Finance Reviews Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expanded Regulatory T cells -Phase 1a trial achieved primary objective of safety and tolerability -PT101 induced potent and selective expansion of regulatory T cells exceeding levels associated with clinical benefit in third-party clinical trials across multiple autoimmune diseases -PT101 maintained selectivity for regulatory T...